TNF in anti-tumour immunity and resistance to immunotherapy | The John Curtin School of Medical Research
November-December 2013 by Harvard Magazine - Issuu
World Journal of Gastroenterology
Dr Jess Michie (@Jess_PhD) / Twitter
Improving CAR-T cell therapy outcomes for patients with for aggressive lymphoma and multiple myeloma | Leukemia and Lymphoma Society
Cancers | Free Full-Text | Analysis of Somatic Mutations in Cancer: Molecular Mechanisms of Activation in the ErbB Family of Receptor Tyrosine Kinases
Selective AKR1C3 Inhibitors Potentiate Chemotherapeutic Activity in Multiple Acute Myeloid Leukemia (AML) Cell Lines | ACS Medicinal Chemistry Letters
Jane Oliaro | Peter MacCallum Cancer Centre
PDF) Androgen-AR axis in primary and metastatic prostate cancer: chasing steroidogenic enzymes for therapeutic intervention
Development of Potent and Selective Inhibitors of Aldo–Keto Reductase 1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase) Based on N-Phenyl-Aminobenzoates and Their Structure–Activity Relationships | Journal of Medicinal Chemistry
Development of highly potent and specific AKR1C3 inhibitors to restore the chemosensitivity of drug-resistant breast cancer - ScienceDirect
Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3 | ACS Medicinal Chemistry Letters
Dr Jess Michie (@Jess_PhD) / Twitter
Insurance Business America issue 2.02 by Key Media - Issuu
A Holiday Message from Craig Ruppert
Page 9 – Leukaemia Foundation
Fall 2013 PALLIUM by Canterbury School - Issuu
Jane Oliaro (@JaneOliaro) / Twitter
Year in review: 2018 at Peter Mac | Peter MacCallum Cancer Centre
Chain Reaction | Beirut
